FDA 483 - B. Braun Aesculap Japan Co., Ltd. - April 10, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of B. BRAUN AESCULAP JAPAN CO., LTD. in Tochigi-Shi, Japan, from April 7-10, 2014, revealed a significant lapse in quality control. The firm failed to document equipment calibrations for a critical environmental monitoring device used in the manufacturing of epidural anesthesia needles, with the device reportedly not calibrated since January 2009. This indicates a potential risk to product quality and patient safety due to uncontrolled manufacturing conditions.
ID · b4fd1cf1-e05b-4e1f-9f2d-89988f5e8741